For national authorities and health care practitioners
2nd edition.
The tool kit provides learning objects and curricular content to support the competencies for those proficiency/trainee levels
Other disorders Chapter H.1
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
International Health and Human Rights (2018) 18:18
Disability awareness, Community, Attitudes, Experts-by-experience
Humanitarian NGOs have made increased use of Private Security Providers (PSPs) over the last decade. There is a gap between the ways that NGOs actually use PSPs and the regulation of this engagement. These guidelines aim to assist humanitarian NGOs in reaching an informed decision about when, how an...d under what conditions to seek PSP services. The guidelines are aimed at operational managers of NGOs, from headquarter to field level. The guidelines do not only cover armed guarding or armed protection, but can be applied to the wide range of services provided by PSPs. Document also available in French.
more
Troubles du Développement
Chapitre C.2
Alcohol misuses
Substance use disorders
Chapter G.1
The new Global AIDS Strategy 2021--2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
Rev Inic Cient e Ext. 2020; 3(2): 483-94; Trata-se de um estudo de revisão integrativa que tem como referencial teórico estudos de abordagem sindrômica dos problemas sobre a temática da recusa vacinal e o movimento antivacinação e os mitos que norteiam essa prática.
Conclusão: O mo...vimento antivacinal traz consequências de saúde, sendo a vacinação um importante meio de prevenção de doenças imunopreveníveis,eos profissionais de saúde e autoridades de saúde são fundamentais na disseminação de notícias fidedignas e educacionais acerca das vacinas.
more
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...oteins in the vessel wall is central to any healthcare strategy to prevent ASCVD. Advances in current concepts about reducing cumulative exposure to apolipoprotein B (apo B) cholesterol-containing lipoproteins and the emergence of novel therapies provide new opportunities to better prevent ASCVD. The present update of the World Heart Federation Cholesterol Roadmap provides a conceptual framework for the development of national policies and health systems approaches, so that potential roadblocks to cholesterol management and thus ASCVD prevention can be overcome.
more